Gynecomastia and Breast Cancer
Gynecomastia and Breast Cancer
By [http://ezinearticles.com/?expert=Dennis_Cheesman]Dennis Cheesman
Most people associate with women. Unfortunately, is not contained just to women. Men can also get breast cancer, even though approximately 99% of all cases occur in women. But one question that many men have is whether men with man boobs, or Gynecomastia, are at a greater risk of developing than men who do not have man boobs.
While women are more susceptible to breast cancer, the fact remains that they are also more likely to survive it than a man will, simply because they are more likely to seek treatment earlier. Men simply are not aware of the risk that they have for breast cancer, however men who have man boobs often fear it.
Men who have male boobs should be worried about breast cancer. In most cases, when a man develops - whether or not he has male boobs - the cause is hormonal changes - specifically a rise in estrogen, which is contributed to the development of man boobs.
It is important, however, to realize that man boobs is not a definite indication that one will develop as well, and is not just a threat for men with man boobs. All men can develop breast cancer. With that said, however, when it comes to in older men and young males, Gynecomastia is a factor, even though the condition itself is not cancerous.
Research has shown that approximately 40% of the men who develop man boobs will also develop breast cancer. Those are staggering numbers, and because that number is so high, it is vital that any male who develops man boobs seek treatment from his health care provider. It is also important for any man, even if he doesn't have man
Estrogen for Triple Negative Breast Cancer
<b>Condition</b>: Female Breast Cancer<br/><b>Intervention</b>: Drug: Estradiol<br/><b>Sponsor</b>: University of Wisconsin, Madison<br/><b>Recruiting</b> - verified March 2010
Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer
<b>Conditions</b>: Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer<br/><b>Interventions</b>: Drug: vorinostat; Drug: ixabepilone<br/><b>Sponsor</b>: City of Hope Medical Center<br/><b>Not yet recruiting</b> - verified March 2010
Female Cancer Patients' Preference For Sexual Health Interventions
<b>Conditions</b>: Breast Cancer; Gynecologic Cancer<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Memorial Sloan-Kettering Cancer Center<br/><b>Recruiting</b> - verified March 2010
Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
<b>Condition</b>: Breast Cancer<br/><b>Interventions</b>: Other: laboratory biomarker analysis; Other: questionnaire administration; Procedure: adjuvant therapy; Radiation: 3-dimensional conformal accelerated partial breast irradiation<br/><b>Sponsors</b>: Radiation Therapy Oncology Group; National Cancer Institute (NCI)<br/><b>Not yet recruiting</b> - verified March 2010
Study of XL147 or XL765 in Combination With Letrozole in Subjects With Breast Cancer
<b>Condition</b>: Breast Cancer<br/><b>Interventions</b>: Drug: XL147; Drug: XL765; Drug: letrozole (Femara)<br/><b>Sponsor</b>: Exelixis<br/><b>Not yet recruiting</b> - verified March 2010
Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence
<b>Condition</b>: Breast Cancer<br/><b>Intervention</b>: <br/><b>Sponsor</b>: AstraZeneca<br/><b>Not yet recruiting</b> - verified March 2010
89Zr-trastuzumab PET for Imaging the Effect of HSP90 Inhibition
<b>Condition</b>: Breast Cancer<br/><b>Intervention</b>: Other: Imaging with 89Zr-trastuzumab PET<br/><b>Sponsor</b>: University Medical Centre Groningen<br/><b>Recruiting</b> - verified February 2010
Evaluating the Age Extension of the NHS Breast Screening Programme
<b>Condition</b>: Breast Cancer Mortality<br/><b>Intervention</b>: Other: Invitation for breast screening<br/><b>Sponsors</b>: University of Oxford; Department of Health, United Kingdom<br/><b>Not yet recruiting</b> - verified March 2010
Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab PET
<b>Condition</b>: Breast Cancer<br/><b>Intervention</b>: Other: 89Zr-bevacizumab PET imaging<br/><b>Sponsor</b>: University Medical Centre Groningen<br/><b>Recruiting</b> - verified February 2010
The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer
<b>Condition</b>: Breast Cancer<br/><b>Intervention</b>: <br/><b>Sponsors</b>: University of Pittsburgh; National Center for Research Resources (NCRR)<br/><b>Recruiting</b> - verified March 2010
A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer
<b>Condition</b>: Neutropenia in Breast Cancer<br/><b>Interventions</b>: Drug: Filgrastim (Eurofarma); Drug: Filgrastim (Granulokine, Amgen)<br/><b>Sponsor</b>: Eurofarma Laboratorios Ltda<br/><b>Not yet recruiting</b> - verified March 2010
Letrozole in Treating Healthy Postmenopausal Women at High Risk for Breast Cancer
<b>Condition</b>: Breast Cancer<br/><b>Intervention</b>: Drug: letrozole<br/><b>Sponsors</b>: University of Arizona; National Cancer Institute (NCI)<br/><b>Not yet recruiting</b> - verified February 2010
Brain Metastasis in Breast Cancer Patients
<b>Condition</b>: Breast Cancer<br/><b>Intervention</b>: Drug: Trastuzumab or Lapatinib<br/><b>Sponsor</b>: GlaxoSmithKline<br/><b>Active, not recruiting</b> - verified February 2010
Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms
<b>Conditions</b>: Breast Cancer; CYP2D6 Polymorphism<br/><b>Intervention</b>: Drug: Tamoxifen<br/><b>Sponsor</b>: Sydney West Area Health Service<br/><b>Not yet recruiting</b> - verified February 2010
Prevention of Capsular Contracture Using Trental and Vitamin E
<b>Condition</b>: Capsular Contractures<br/><b>Intervention</b>: Drug: Trental<br/><b>Sponsor</b>: Legacy Health System<br/><b>Recruiting</b> - verified March 2010
Lymph Fluid and Blood Collection for Identification of Novel Biomarkers
<b>Condition</b>: Adenocarcinoma of the Breast<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Indiana University<br/><b>Not yet recruiting</b> - verified February 2010
Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats
<b>Conditions</b>: Ovarian; Breast; Prostate; Pancreatic; Advanced Tumours<br/><b>Intervention</b>: Drug: olaparib<br/><b>Sponsor</b>: AstraZeneca<br/><b>Recruiting</b> - verified March 2010
Carcinogenicity Study of Bupropion
<b>Conditions</b>: Depressive Disorder; Cancer<br/><b>Interventions</b>: Drug: Regular bupropion use; Drug: Regular SSRI (Selective serotonin reuptake inhibitors) use; Drug: Regular use of any other antidepressant; Drug: Regular TCA (Tricyclic antidepressants) use<br/><b>Sponsor</b>: GlaxoSmithKline<br/><b>Active, not recruiting</b> - verified February 2010
Pilot Pharmacokinetic Study of Daily Versus Monthly High-Dose Cholecalciferol Supplementation
<b>Condition</b>: Healthy Volunteers<br/><b>Interventions</b>: Dietary Supplement: Single High Dose Cholecalciferol; Dietary Supplement: Daily Dose Cholecalciferol<br/><b>Sponsor</b>: Mayo Clinic<br/><b>Recruiting</b> - verified March 2010
boobs, to be aware of the signs of breast cancer.
Family history does play a role, even if you do not develop Gynecomastia. Approximately 20% of the men who develop at some point in life have a family history of - from either male or female relatives. In other words, if a man's mother had breast cancer, his risk for developing is higher than the average man's - regardless of whether or not he has man boobs.
Again, it is important for every man to be aware of the symptoms which include a lump in the breast, nipple discharge, a retracted nipple, and/or ulcerations on the breast. It is important to note that lumps that indicate will not be painful, which is why they are often ignored by men.
Ironically, while men who have man boobs are at a greater risk of developing than men who do not, those who do have male boobs have a greater chance of survival. This is because if you have man boobs, the cancer will typically be further away from the chest cavity, reducing the speed at which the cancer spreads, whereas if you do not have man boobs, the cancer is right next to the chest cavity, and the cancer spreads quickly.
You can get more information on man boobs by visiting our new site that teaches you all about [http://www.tipstolosemanboobs.com]man boobs. Also, there is a system that teaches you [http://www.tipstolosemanboobs.com/how-to-get-rid-of-man-boobs.html]How To Get Rid Of Man Boobs!
Article Source: http://EzineArticles.com/?expert=Dennis_Cheesman http://EzineArticles.com/?Gynecomastia-and-Breast-Cancer&id=1143216
|
